Erik Glen Alvstad

Erik Glen Alvstad

Auto-generated profile, based on publicly available information

Erik Glen Alvstad

Center for Epigenetics and Metabolism, Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
YCYoungseo Cheon
Youngseo Cheon
EAErik Glen Alvstad
Erik Glen Alvstad
DTDenis Torre
Denis Torre
DQDaniel Tu Quach
Daniel Tu Quach
JNJennifer Nguyen
Jennifer Nguyen
IMIvan Marazzi
Ivan Marazzi
Transposable elements (TEs) in the human genome are the heritage of ancient parasitic infections. While most of human DNA comprises TEs and TE-derived elements, their repetitive nature poses technical challenges; thus, little is known about their positional identity and regulatory roles. Here, by integrating long-read and multidimensional transcriptional analyses, we investigate when, where and how TEs become part of a gene. We characterize how TE-derived isoforms change across mouse–human variation and how they are linked to gene regulatory networks controlling cell states during differentiation, organogenesis and health (aging and pathological states). Mechanistically, we identify an RNA degradation-dependent and splicing-dependent quality control mechanism that operates independently of conventional mechanisms of TE suppression, such as DNA methylation and heterochromatinization, and prevents TE-chimera expression and TE-induced cell differentiation. Overall, our findings unveil mechanisms by which viral-derived elements enhance transcriptome plasticity.

19 August 2025 in bioRxiv
Verified
Preprint
Open access
LSLindsey V. Soles
Lindsey V. Soles
SLShuangyu Li
Shuangyu Li
LLLiang Liu
Liang Liu
KSKristianna S.K. Sarkan
Kristianna S.K. Sarkan
EAErik G. Alvstad
Erik G. Alvstad
YSYongsheng Shi
Yongsheng Shi
SUMMARY: Eukaryotic pre-mRNA processing steps, including splicing and 3′ processing, are tightly coordinated, yet the underlying mechanisms remain incompletely understood. U1 snRNP has been proposed to inhibit 3′ processing at intronic polyadenylation (IPA) sites through a splicing-independent mechanism termed telescripting. In contrast, we discovered that disrupting splicing—by targeting various key components such as U1 snRNP, U2 snRNP, U2AF, and SF3b—activates 3′ processing at thousands of IPA sites. Notably, splicing inhibition, especially of U1 snRNP, induced widespread premature transcription termination within gene bodies through both IPA-coupled and -independent mechanisms. Different splicing factors activated overlapping and distinct sets of IPA sites, reflecting their specific contributions to transcription and spliceosome function. Conversely, inhibition of 3′ processing enhanced splicing globally. These findings support a model in which splicing and 3′ processing are competing processes that intersect with transcription to shape the transcriptome landscape.